Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Plus Therapeutics, Inc. (NASDAQ: PSTV)
PSTV Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
PSTV Stock Analysis
PSTV
PE Ratio:
0.3
PSTV
PEG Ratio:
Not Available
PSTV
Forward EPS Growth (12 month):
0.00%
PSTV
PS Ratio:
2.5
PSTV
PSG Ratio:
PSTV
Forward Revenue Growth (12 month):
261.50%
PSTV Articles
No data was found